2020
DOI: 10.3390/nu12092494
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factors for Muscle Loss in Hemodialysis Patients with High Comorbidity

Abstract: With expanding kidney transplantation programs, remaining hemodialysis patients are more likely to have a high comorbidity burden and may therefore be more prone to lose muscle mass. Our aim was to analyze risk factors for muscle loss in hemodialysis patients with high comorbidity. Fifty-four chronic hemodialysis patients (Charlson Comorbidity Index 9.0 ± 3.4) were followed for 20 weeks using 4-weekly measurements of lean tissue mass, intracellular water, and body cell mass (proxies for muscle mass), handgrip … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 48 publications
(51 reference statements)
1
9
0
Order By: Relevance
“…Nevertheless, the difference did not achieve statistical significance, most likely due to the small sample size. DM as a covariate in the multivariate model was also not associated with greater LTM loss over time [31]. We intend to verify the observations of Marcelli et al and Visser et al with serial BIA assessments during the follow-up of our studied group.…”
Section: Discussionsupporting
confidence: 63%
“…Nevertheless, the difference did not achieve statistical significance, most likely due to the small sample size. DM as a covariate in the multivariate model was also not associated with greater LTM loss over time [31]. We intend to verify the observations of Marcelli et al and Visser et al with serial BIA assessments during the follow-up of our studied group.…”
Section: Discussionsupporting
confidence: 63%
“…Chronic kidney disease is one of the most important etiologies of secondary sarcopenia, especially when HD is required. Although some studies have shown that lean body mass loss was not marked in patients undergoing HD 17 19 , a previous report showed that patients receiving HD who could not receive kidney transplantation due to comorbidities had a decrease in lean body mass by 17.1% in 20 weeks 20 . In this study, the participants receiving HD had a mean age of approximately 70 years, and their median annual %PMI was −9.5%.…”
Section: Discussionmentioning
confidence: 92%
“…However, studies have demonstrated the safety and feasibility of promoting rehabilitation and early mobilization in ICU with femoral dialysis catheter [40,41]. Patients undergoing renal replacement therapy often experience loss of muscle mass secondary to progression of kidney disease, a decrease in protein synthesis, an increase in proteolysis, acidosis, inflammation, and the use of corticosteroids, which contributes to a catabolic state [42,43].…”
Section: Plos Onementioning
confidence: 99%